eMeasure Name | Pneumonia Vaccination Status for Older Adults | eMeasure Id | 38d3c446-df8e-4cc7-b3f5-90ea538c40d5 |
Version number | 1 | eMeasure Set Id | aa066eed-e8f6-4fec-8084-61d3d1e8b6e2 |
Available Date | No information | Measurement Period | January 1, 20xx through December 31, 20xx |
Measure Steward | National Committee for Quality Assurance | ||
Endorsed by | National Quality Forum | ||
Description | The percentage of patients 65 years of age and older who have ever received a pneumococcal vaccine. | ||
Copyright | © National Committee for Quality Assurance. All Rights Reserved |
||
Measure scoring | Proportion | ||
Measure type | Process | ||
Stratification | None |
||
Risk Adjustment | None |
||
Data Aggregation | |||
Rationale | This measure monitors the appropriate and timely use of vaccines among age-appropriate older adults. Each year, 20% of Americans contract influenza (flu) (CDC 2009). Rates of infection are highest among children and immunosuppressed patients, while mortality is highest among adults over 64 years, children under 2 years and persons with chronic medical conditions (CDC 2008). More than 200,000 people are hospitalized for flurelated complications each year; 63% are 65 or older (CDC 2009; Thompson et al. 2004). The health impact of influenza on older adults is substantial and flu short vaccines are the most effective way to prevent severe illness complications and death. This measure facilitates efforts toward infectious disease prevention among a vulnerable subgroup of the population. |
||
Clinical Recommendation Statement | The U.S. Preventive Services Task Forces Guide to Clinical Preventive Services recommends pneumococcal vaccine for all immunocompetent individuals who are 65 and older or otherwise at increased risk for pneumococcal disease. Routine revaccination is not recommended, but may be appropriate in immunocompetent individuals at high risk for morbidity and mortality from pneumococcal disease (e.g., persons 75 years of age or with severe chronic disease) who were vaccinated more than five years previously (USPSTF, 1989). |
||
Improvement notation | Higher score indicates better quality |
||
Measurement duration | 12 month(s) |
||
Reference | United States Preventive Services Task Force. Guide to Clinical Preventive Services. Baltimore: Williams & Wilkins, 1989. 791-814. |
||
Definition | Initial Patient Population(s): All patients 65 years of age and older during the measurement period. |
||
Definition | Denominator(s): Patients in the initial population with an encounter during the measurement period. |
||
Definition | Denominator Exclusion(s): N/A |
||
Definition | Numerator(s): The number of patients who have received a pneumococcal vaccination. |
||
Definition | Denominator Exception(s): N/A |
||
Guidance | Numerator element: Pneumococcal vaccination is expected once ever for patients 65 years of age or older. There is no clear standard location for documentation in EHRs of pneumococcal vaccination that is administered external to the providers practice. The measure specification assumes that administered vaccines will be documented in the medication administration record. In a truly interoperable environment, even medications administered elsewhere could be captured in the medication administration record. In absence of such interoperability the implementer may need to look elsewhere in the medical record for evidence of vaccine administered in other setting, e.g., a preventive care screening record. |
||
Supplemental Data Elements | Report "Patient Characteristic: Gender" using "Gender HL7 Value Set (2.16.840.1.113883.1.11.1)"; Report "Patient Characteristic: Race" using "Race CDC Value Set (2.16.840.1.114222.4.11.836)"; Report "Patient Characteristic: Ethnicity" using "Ethnicity CDC Value Set (2.16.840.1.114222.4.11.837)"; Report "Patient Characteristic: Payer" using "Payer Source of Payment Typology Value Set (2.16.840.1.113883.3.221.5)". |
Measure set | CLINICAL QUALITY MEASURE SET 2011-2012 |